Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Beth Overmoyer, MD

Medical Oncology

Make an Appointment
Watch Video


  • Director, Inflammatory Breast Cancer Program
  • Institute Physician
  • Associate Professor of Medicine, Harvard Medical School

Clinical Interests

  • Breast cancer genetics
  • Systemic treatment of breast cancer
  • Treatment of inflammatory breast cancer

Diseases Treated

Contact Information

  • Appointments617-632-2175 (new)
    617-632-3800 (follow-up)
  • Office Phone Number617-632-3800
  • Fax617-632-1930


Dr. Overmoyer launched the Inflammatory Breast Cancer (IBC) Program at DF/BWCC in 2009, where she continues to serve as the principal investigator of many IBC research programs and clinical trials. She began her oncology career in 1989 at the University of Pennsylvania, where she trained in breast cancer and also participated in a major study in inflammatory breast cancer. She went on to develop the breast cancer program at the Cleveland Clinic and later developed two National Cancer Institute-sponsored studies on angiogenesis inhibitors and inflammatory breast cancer.

Board Certification:

  • Hematology
  • Internal Medicine, 1989
  • Medical Oncology


  • Hospital of the University of Pennsylvania, Hematology/Oncology


  • Hospital of the University of Pennsylvania, Internal Medicine

Medical School:

  • Case Western Reserve University School of Medicine


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions